Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Deloitte
Citi
Baxter
Argus Health
Cipla
Johnson and Johnson
Fish and Richardson

Generated: November 14, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for GDC-0623

« Back to Dashboard

US Patents for GDC-0623

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GDC-0623 ➤ Sign Up 5-anilinoimidazo[1,5-a]-pyridines inhibitors of MEK kinase Genentech, Inc. (South San Francisco, CA) ➤ Sign Up
GDC-0623 ➤ Sign Up 5-anilinoimidazopyridines and methods of use Genentech, Inc. (South San Francisco, CA) ➤ Sign Up
GDC-0623 ➤ Sign Up Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer GENENTECH, INC. (South San Francisco, CA) ➤ Sign Up
GDC-0623 ➤ Sign Up 5-anilinoimidazopyridines and methods of use Genentech, Inc. (South San Francisco, CA) ➤ Sign Up
GDC-0623 ➤ Sign Up Polymorphs of 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazole-5-yl)-5,6-dihydrobenzo[F]- imidazo [1,2-D][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide, methods of production, and pharmaceutical uses thereof Genentech, Inc. (South San Francisco, CA) ➤ Sign Up
GDC-0623 ➤ Sign Up Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hyperproliferative diseases Genentech, Inc. (South San Francisco, CA) ➤ Sign Up
GDC-0623 ➤ Sign Up Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors Genentech, Inc. (South San Francisco, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for GDC-0623

Drugname Country Document Number Estimated Expiration Related US Patent
GDC-0623 Argentina 069803 2027-12-19 ➤ Sign Up
GDC-0623 Australia 2008343065 2027-12-19 ➤ Sign Up
GDC-0623 Brazil PI0819529 2027-12-19 ➤ Sign Up
GDC-0623 Canada 2706571 2027-12-19 ➤ Sign Up
GDC-0623 China 101945870 2027-12-19 ➤ Sign Up
GDC-0623 Cyprus 1114663 2027-12-19 ➤ Sign Up
GDC-0623 Cyprus 1116681 2027-12-19 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
McKinsey
Fish and Richardson
Cipla
UBS
Colorcon
Deloitte
Cantor Fitzgerald
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.